SUNNYVALE, Calif., April 9, 2018 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) will report results for its third
quarter ended March 31, 2018 on
Monday, April 30, 2018 after the
market close, following the annual European Society for
Radiotherapy and Oncology (ESTRO) meeting taking place the week
before in Barcelona. Management will host a conference
call to review the third quarter results at 1:30 p.m. PT/4:30 p.m.
ET on April 30, 2018.
The conference call dial-in numbers are 855-867-4103
(USA) or 262-912-4764
(International). In addition, a dial up replay of the
conference call will be available approximately one hour after the
call's conclusion for one week. The replay number is
855-859-2056 (USA), or
404-537-3406 (International), Conference ID: 7359669.
A live webcast of the call will also be available from the
Investor Relations section of the Company's website at
investors.accuray.com. A webcast replay can be accessed on
the website and will remain available until Accuray announces its
results for the fourth quarter of fiscal 2018.
About Accuray
Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology
company that develops, manufactures and sells precise, innovative
tumor treatment solutions that set the standard of care with the
aim of helping patients live longer, better lives. The
Company's leading-edge technologies deliver the full range of
radiation therapy and radiosurgery treatments. For more
information, please visit www.accuray.com
|
Contacts:
|
|
|
|
|
Investors:
|
Todd Kehrli, EVC
Group, 310-625-4462, tkehrli@evcgroup.com
|
|
Jim Byers, EVC Group,
415-309-2079, jbyers@evcgroup.com
|
|
Michael Polyviou, EVC
Group, 732-933-2754, mpolyviou@evcgroup.com
|
|
|
|
Media:
|
Beth
Kaplan
|
|
Accuray
|
|
408-789-4426
|
|
bkaplan@accuray.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/accuray-to-report-fiscal-2018-third-quarter-financial-results-on-april-30-2018-300626044.html
SOURCE Accuray Incorporated